Should You Centralize Cold Chain Fulfillment? Only If You’ve Solved Distribution First
Cold chain is a logistics problem — not just a throughput problem. Pharmacies must rethink their strategy, not just automate it.
Cold chain is a logistics problem — not just a throughput problem. Pharmacies must rethink their strategy, not just automate it.
Using Section 232 national-security tariffs on imported medical equipment risks repeating the same mistakes that have long plagued U.S. health policy: relying on blunt instruments for complex problems.
Success requires orchestrating an end-to-end experience that connects manufacturing, logistics, clinical sites, payers, and patients seamlessly. The companies that treat this orchestration as a strategic competency, rather than just operational logistics, will be best positioned to scale.
From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out
From stock transparency and supplier diversification to AI shipping and cart negotiations, novel solutions are emerging to revolutionize procurement and logistics of medical supplies at healthcare organizations.
MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
Microsoft seeks to change the way pharma industry companies use technology to better navigate human resource and supply chain challenges.
Two years after acquiring PillPack, Amazon is launching its much-anticipated pharmacy business. But even with some exciting features about price transparency, it's unlikely to dramatically change prescription costs, experts said.
Health IT companies across revenue cycle management, behavioral health, cybersecurity, supply chain and other areas highlight new developments and share how they have responded to the challenges of the Covid-19 pandemic.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business
The company's machine learning tools have been used to reduce wait times in the emergency room and to make more efficient use of operating rooms, among other areas.
DSV, a global logistics business, notes on its website that supply chain visibility is the biggest challenge to getting supplies delivered on time. Parachute Health is one company that is using its technology to address this challenge and ensure patients get medical equipment on time.
Manufacturers must carefully consider the integrated logistics required to bring therapies like Kymriah and Yescarta to market, a process requiring more coordination than the commercialization of traditional therapies.
Baxter Ventures led the round and new investor Black Granite Capital also participated, along with established investors.